Product Information
UMECLIDINIUM-VILANTEROL ELLIPTA 62.5-25 MCG INH is a generic product labeled by Prasco Laboratories, priced at $4.9550 per EA under NDC 66993013497. Its NADAC has been published 68 times since Jun 18, 2025.
FDA first approved this application on Dec 18, 2013.
UMECLIDINIUM-VILANTEROL ELLIPTA 62.5-25 MCG INH
umeclidinium bromide and vilanterol trifenatateStrength
62.5; 25 ug/1; ug/1
Manufacturer
Prasco LaboratoriesNDC
66993013497
Classification
Generic
Dosage Form
POWDER
Route
RESPIRATORY (INHALATION)
Effective Date
9/23/2026
Active Ingredients
UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA203975FDA Approved
12/18/2013
On Market Since
4/11/2025
Pharmacological Classes
Price Statistics
The NADAC for UMECLIDINIUM-VILANTEROL ELLIPTA 62.5-25 MCG INH has been published 68 times since Jun 18, 2025, and over the history we have for it it has risen 6.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.9550 per EA |
|---|---|
| All-time high | $4.9841 (Dec 10, 2025) |
| All-time low | $4.6565 (Jun 18, 2025) |
| 52-week high | $4.9841 |
| 52-week low | $4.8701 |
| Median price | $4.9169 |
| Average price | $4.8825 |
| Largest weekly change | +2.8% (Sep 17, 2025) |
| Weeks tracked | 68 |
| Tracking since | Jun 18, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Prasco Laboratories manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
umeclidinium bromide and vilanterol trifenatate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anticholinergic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of UMECLIDINIUM-VILANTEROL ELLIPTA 62.5-25 MCG INH?
The current National Average Drug Acquisition Cost (NADAC) for UMECLIDINIUM-VILANTEROL ELLIPTA 62.5-25 MCG INH, manufactured by Prasco Laboratories, is $4.9550 per EA (NDC 66993013497), effective Sep 30, 2026.
How has the price of UMECLIDINIUM-VILANTEROL ELLIPTA 62.5-25 MCG INH changed over time?
Over the history we have for it, the NADAC for UMECLIDINIUM-VILANTEROL ELLIPTA 62.5-25 MCG INH has risen 6.4%. It has been tracked across 68 weekly CMS publications since Jun 18, 2025.
What are the highest and lowest recorded NADAC prices for UMECLIDINIUM-VILANTEROL ELLIPTA 62.5-25 MCG INH?
Since Jun 18, 2025, the NADAC for UMECLIDINIUM-VILANTEROL ELLIPTA 62.5-25 MCG INH has ranged from a low of $4.6565 (Jun 18, 2025) to a high of $4.9841 (Dec 10, 2025), with a median of $4.9169 per EA.
Are there cheaper alternatives to UMECLIDINIUM-VILANTEROL ELLIPTA 62.5-25 MCG INH?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as UMECLIDINIUM-VILANTEROL ELLIPTA 62.5-25 MCG INH in a comparable dosage form, but none are currently priced below it.
Who manufactures UMECLIDINIUM-VILANTEROL ELLIPTA 62.5-25 MCG INH?
UMECLIDINIUM-VILANTEROL ELLIPTA 62.5-25 MCG INH (NDC 66993013497) is labeled by Prasco Laboratories, and CMS classifies it as a generic product.